TCL Archive Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation May 9, 2014
TCL Archive FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization January 28, 2011
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted. June 20, 2003
TCL Archive A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion. June 4, 2004
